CD57 Antibody IHC

CD57 Antibody IHC
This antibody is intended for in vitro diagnostic (IVD) use.
 
The CD57 (IHC539) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated, subsequent to clinical differential diagnoses of diseases, as an aid in the identification of T-cell large granular lymphocyte disorders, oligodendrogliomas, and neuroendocrine tumors within the context of antibody panels, the patient’s clinical history and other diagnostic tests evaluated by a qualified pathologist.
 
Cluster of differentiation 57 (CD57), also known as NK-1, is an antigen detectable in natural killer cells, some T-lymphocytes and normal peripheral blood mononuclear cells, myeloid cells, and a variety of polypeptides, lipids, and chondroitin sulfate proteoglycans. CD57 is indicated as a marker for tumors of neuroendocrine origin, including pheochromocytomas, paragangliomas, carcinoid tumor, and medulloblastomas, as well as various neural tumors including neuromas, neurofibromas, schwannomas, and granular cell tumors. CD57 is also detectable in ganglioneuroma and prostate carcinoma. Anti-CD57 is used to distinguish nodular lymphocyte-predominant Hodgkin’s lymphoma from T-cell/histiocyte-rich large B-cell lymphoma, nodular sclerosis Hodgkin’s disease, and follicular lymphoma.

Write a review

    Bad           Good

Protocol
786-1433
786-1434
786-1435
Material Safety Data Sheet
786-1433
English_US
786-1434
English_US
786-1435
English_US
Catalog Description Size Price(USD) Qty
786-1433
IHC Ab: CD57 0.1ml
$168.00
786-1434
IHC Ab: CD57 1ml
$735.00
786-1435
IHC Ab: CD57 5ml
$3,200.00